Conference Paper: Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract)

File Download
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEfficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract)
AuthorsYau, TCC
Leung, RCY
Wong, H
Chiu, J
Chan, P
Pang, RWC
Fan, ST
Poon, RTP
Issue Date2011
CitationESMO 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 22-25 June 2011. Annals of Oncology, v. 22 n. Suppl 5 [How to Cite?]
DC Field
Value
dc.contributor.authorYau, TCC
dc.contributor.authorLeung, RCY
dc.contributor.authorWong, H
dc.contributor.authorChiu, J
dc.contributor.authorChan, P
dc.contributor.authorPang, RWC
dc.contributor.authorFan, ST
dc.contributor.authorPoon, RTP
dc.date.accessioned2011-08-26T14:36:33Z
dc.date.available2011-08-26T14:36:33Z
dc.date.issued2011
dc.identifier.citationESMO 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 22-25 June 2011. Annals of Oncology, v. 22 n. Suppl 5 [How to Cite?]
dc.identifier.hkuros189740
dc.identifier.issueSuppl 5
dc.identifier.urihttp://hdl.handle.net/10722/137895
dc.identifier.volume22
dc.languageeng
dc.relation.ispartofESMO 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 22-25 June 2011. Annals of Oncology
dc.titleEfficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract)
dc.typeConference_Paper